NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
NEREUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEREUS
ST13
US500000097650292Class
1, 5, 9, 10, 24
Filing
97650292
Registration
7583486
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
12/03/2024
Trademark type
Word
Nice classes
1, 5, 9, 10, 24
Filing date
10/27/2022
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Comberton, Cambridge, GB
Examiner
KLUWE, CHERYL
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ASTREA UK SERVICES LIMITED
Representatives
Ben Natter HAUG PARTNERS, LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 24
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nanofiber filtering compositions for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; nanofiber filtering materials for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; biochemical and chemical preparation material for chromatographic purification of chemical and biological substances other than for medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicals other than for medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and nucleic acids for development of viral vectorsextracellular vesicles and advanced therapeutic medicinal products; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations other than for medical or veterinary purposes; chemicals and biologicals for use in bioseparation for protein purificationnucleic acid purificationviral particle purification extracellular vesicle purification and purification of advanced therapeutic medicinal products; chemicals and biologicals for use in filtering of proteinsnucleic acidsviral particlesextracellular vesicles and advanced therapeutic medicinal products; chemical and biological substances for use in separation for protein purificationnucleic acid purificationviral particle purificationextracellular vesicle purification and purification of advanced therapeutic medicinal product; fibres of inorganic material for separation purposes for viral particle purification; fibres of organic material for separation purposes for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial usereagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemicalantibodies and antibody fragments for in vitro scientific or research use.
Class 5
Proteins for medical diagnostic purposes; enzymes for medical use; nucleic acids for medical use; extracellular vesicles for medical use; advanced therapeutic medicinal products for medical use; proteinsnamely nucleic acids for medical use; proteinsnamely extracellular vesicles for medical use; proteinsnamely advanced therapeutic medicinal products for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues biochemical and chemical preparation material for chromatographic purification of chemical and biological substancesfor medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicalsfor medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsfor medical or veterinary purposes.
Class 9
Scientific research and laboratory apparatuslaboratory filters for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; scientific purification apparatuslaboratory filters used for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; laboratory filters and purifiers for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; filtering and separation apparatus for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; apparatus for bioseparation for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; membranes and nanofibers for filtration for laboratory use; separation columns and separation devices for scientific purposes; bioprocessing columns for scientific purposes; chromatography apparatus and instruments for scientific purposes; temperaturepressure and optical sensors for bioprocessing apparatus and equipment.
Class 10
Diagnosticexamination and monitoring equipmentmedical diagnostic apparatus for filtering and testing of proteinsnucleic acidsviral particles and extracellular vesicles; purification apparatus for filtering and testing of proteinsnucleic acidsviral particles extracellular vesicle and advanced therapeutic medicinal product for medical purposes; filtering and separation apparatus for filtering and testing of proteinsnucleic acidsviral particlesextracellular vesicles and advanced therapeutic medicinal products for medical purposes; medical and veterinary apparatus for bioseparationproteinnucleic acidviral particle and extracellular vesicle separation apparatus; membranes and nanofibres for filtration being filters for medical purposesproteinnucleic acidviral particle and extracellular vesicle filters; separation instruments for medical use being filters for medical purposesproteinnucleic acidviral particle and extracellular vesicle filters.
Class 24
Composite electrospun nanofiber material for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofibre textiles for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofiber filtering cloth for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration and purification.
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/21/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/16/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/16/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/30/2024
GNFR
FINAL REFUSAL E-MAILED
01/30/2024
CNFR
FINAL REFUSAL WRITTEN
01/30/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/16/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2023
GNRT
NON-FINAL ACTION E-MAILED
07/17/2023
CNRT
NON-FINAL ACTION WRITTEN
07/17/2023
DOCK
ASSIGNED TO EXAMINER
06/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2022
NWAP
NEW APPLICATION ENTERED
10/31/2022
Continuous trademark protection
Get notified about every new filing that threatens NEREUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.